Earnings Call Summary | LSB Industries(LXU.US) Q1 2024 Earnings Conference
Earnings Call Summary | LSB Industries(LXU.US) Q1 2024 Earnings Conference
The following is a summary of the LSB Industries, Inc. (LXU) Q1 2024 Earnings Call Transcript:
以下是LSB工業公司（LXU）2024年第一季度業績電話會議記錄摘要：
Financial Performance:
財務業績：
LSB Industries reported Q1 adjusted EBITDA of $33 million and EPS of $0.08.
The company repurchased $33 million of its notes and about 700,000 shares of stock during Q1, totaling $75 million of debt and 1.5 million shares repurchased year-to-date.
The expected Q2 2024 adjusted EBITDA will be lower than Q2 2023 due to lower selling prices, but is anticipated to increase sequentially over Q1 2024 due to higher sales volumes and lower natural gas costs.
LSB Industries報告稱，第一季度調整後的息稅折舊攤銷前利潤爲3,300萬美元，每股收益爲0.08美元。
該公司在第一季度回購了3,300萬美元的票據和約70萬股股票，年初至今共回購了7500萬美元的債務和150萬股股票。
由於銷售價格降低，預計2024年第二季度調整後的息稅折舊攤銷前利潤將低於2023年第二季度，但由於銷量增加和天然氣成本降低，預計將比2024年第一季度連續增長。
Business Progress:
業務進展：
LSB Industries continues to work on two low-carbon ammonia projects and numerous improvements to plant operations.
Participation in multiple conferences in June is expected to further their business reach.
The company is on track to reach their target leverage ratio through a combination of debt and stock buyback.
They are exploring the possibility of partnering with Amogy to open up new markets for the use of low-carbon ammonia.
Business initiatives focus on decreasing the carbon footprint in the mining industry and improving product mix for better margins in fertilizer sales.
The company plans for a urea expansion at Pryor in the next plant turnaround for improved operational rates, while expecting additional expenditure on SG&A related to reliability programs.
LSB Industries繼續開展兩個低碳氨項目，並對工廠運營進行了多項改進。
預計在6月份參加多個會議將擴大他們的業務範圍。
該公司有望通過債務和股票回購相結合來達到其目標槓桿率。
他們正在探索與Amogy合作的可能性，爲使用低碳氨開闢新的市場。
業務舉措側重於減少採礦業的碳足跡和改善產品組合，以提高化肥銷售的利潤率。
該公司計劃在下次工廠週轉時擴建Pryor的尿素以提高運營率，同時預計與可靠性計劃相關的銷售和收購支出將增加。
More details: LSB Industries IR
更多詳情： LSB 工業投資者關係
Tips: For more comprehensive details, please refer to the IR website. The article is only for investors' reference without any guidance or recommendation suggestions.
提示：欲了解更多詳情，請訪問投資者關係網站。本文僅供投資者參考，不構成任何投資建議。
譯文內容由第三人軟體翻譯。